Bolt Biotherapeutics has announced the acquisition of fellow USA-based Prana Therapies, a clinical-stage biotechnology company pioneering next-generation half-life-extended multispecific antibodies ...
The European Commission has approved an indication extension for Johnson & Johnson's Tecvayli (teclistamab) as monotherapy ...
Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely ...
Danish drugmaker Novo (NOV: N) and US pharma major Eli Lilly (NYSE: LLY) are competing across a widening range of obesity ...
Shares in UCB, the Belgian biopharma company, closed 21.6% higher at 259.10 euros on Thursday after it raised its 2026 ...
Zymeworks, the Vancouver-based biotech, has signed an exclusive global license and collaboration agreement with Roche for ...
US pharma major AbbVie yesterday announced positive top-line results from the Phase III INTREPID study evaluating the safety ...
US pharma major Merck & Co (NYSE: MRK) and US biotech Moderna (Nasdaq: MRNA) have reported detailed Phase III results showing ...
Pharmaceutical companies’ reliance on Chinese suppliers extends from early laboratory work to the production of medicines for ...
The US Treasury Department has proposed adding biotech to the sectors covered by its outbound investment rules, a move that ...
US biotech Star Therapeutics, which is focused on the discovery and development of life-changing therapies for diseases with ...
Danish clinical-stage techbio Evaxion has announced new three-year immune and clinical outcome data for personalized cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results